Drug & medication recalls Moderate risk

Fentanyl 500mcg and Ropivacaine HCl 250mg added to 0 recalled over sterility concerns

Recall date
February 8, 2023
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Apollo Care recalls Fentanyl 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (1mg/mL) added to 250mL 0.9% Sodium Chloride, For Epidural Use Only…
Recall number
D-0487-2023
FDA classification
Class II
Brand / firm
Apollo Care
Sold / distributed
MO

Why it was recalled

Lack of assurance of sterility: Suspected microbial growth present on external label packaging.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Fentanyl 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (1mg/mL) added to 250mL 0.9% Sodium Chloride, For Epidural Use Only, Rx only, 3801 Mojave Ct. Suite 101, Columbia, MO 65202, NDC 71170-950-25

Get recall alerts

Free email alert whenever Apollo Care has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Apollo Care